Medable

11/13/2025

If almost half of a drug's development time is spent in 'white space,' is progress taking a backseat to process?

Every protocol amendment, data query, and regulatory handoff adds friction to a framework already stretched to its edge.

Agentic AI changes the equation. It connects systems and automates time-draining admin, turning the in-between into forward motion.

If you're tired of pausing between clinical milestones, learn more from Medable's Andrew Mackinnon here: https://pharmaphorum.com/rd/leveraging-ai-agents-eliminate-white-space-clinical-trials
________

Human-AI collaboration has the potential to mitigate gross productivity gaps and establish a new standard of clinical trial efficiency.

11/12/2025

If you're tired of too many oversight meetings, localization delays, and study builds that take weeks instead of days, this virtual session is for you! 🎥

During a live demo, you'll see exactly how clinical teams are:
🟣 Consolidating 3 review meetings into just 1.
🟣 Building eCOAs 35X faster.
🟣 Cutting translation timelines by 75%,
🟣 Gaining up to 6 weeks back to focus on what matters: science and patients.

👉 Secure your spot here: https://globalmeet.webcasts.com/starthere.jsp?ei=1738656&tp_key=d42bde5532
________

11/10/2025

High patient retention ✅. Low operational burden ✅. No EDC required ✅.

The Medable platform is powering a decade-long, global long-term follow-up (LTFU) obesity study. At present, our customer has achieved a 97% patient retention rate without using a traditional EDC system, all while delivering a compliant, scalable, and cost-efficient approach.

👉 Learn more here: https://www.medable.com/knowledge-center/long-form-long-form-driving-a-high-adherence-ltfu-trial-without-an-edc
________

11/10/2025

Clinical trials are cracking under their own weight. They're too complex, too slow, and too manual.

That’s where Agentic AI comes in. Built to think, decide, and act alongside people to redefine trial ex*****on and outcomes.

Medable’s approach goes beyond automation, giving every team an intelligent partner that helps turn idle time into active progress across every phase of development.

Learn more here: https://www.medable.com/knowledge-center/guides-building-blocks-agentic-ai-is-transforming-trial-design-management-and-outcomes
________

11/07/2025

Still waiting for AI that actually works for clinical research? That’s what Medable’s Agent Studio delivers, automating the manual, accelerating the complex, and augmenting human effort so your teams get the support they need.

If you're heading to ESMO AI & Digital next week, reach out to Sam FieldWick, Lorraine Graham, or Rana Khan to learn more!
________

11/06/2025

As decentralized trials evolve, AI is becoming the engine driving efficiency and smarter insights.

Tomorrow at the DTRA Annual Meeting, Medable’s Alison Holland will join industry peers to explore how AI can simplify DCTs, making research more scalable, actionable, and patient-centered.

Add the session to your calendar so you don't miss the live discussion!
________

11/05/2025

🚀 Big ideas. Bold innovation. Real impact.

Today at , Medable's Alison Holland is moderating the Perspectives on AI panel, diving into how new technologies are reshaping the way we design, measure, and deliver clinical research.

Add this session to your agenda so you don't miss the latest insights from across the industry!
________
Panel speakers:
Paul Ashley, Director, External Innovation, Data Science and Digital Health, Johnson & Johnson
Sharmin Nasrullah, GM, Life Sciences, R&D Clinical, Salesforce
Steve Rosenberg, Chief Executive Officer, uMotif
Andrew Trister, Chief Medical and Scientific Officer, Verily
Kushal Gohil, SVP, Global Project Leadership & Launch Excellence, Parexel
________

11/04/2025

🔍 How do we turn technology innovation into real-world impact for patients?

At the Pfizer Digital Implementation Summit, Medable’s Musaddiq Khan will join R&D leaders to discuss how to leverage digital health tools (DHTs) & digital measures to deepen engagement, enhance data quality, and accelerate research outcomes.

Don’t miss this important conversation driving the next era of connected, patient-centered research.

👉 If you're in Cambridge, MA, tomorrow and would like to attend, register now: https://digitalimplementation.panagorapharma.com
________

10/30/2025

Here’s the truth: between 70% and 80% of clinical trial work is still done manually by humans who need more support. That’s not innovation. That’s inertia.

At CNS Summit, see how Medable’s Agent Studio is changing the game, using responsible agentic AI to automate the repetitive, accelerate timelines, and free teams to focus on science, not admin.

Stop managing inefficiency. Start driving breakthroughs. Meet with us at the event to see it in action!

Schedule time with our team here: https://info.medable.com/CNS_Summit_Meetings_2025.html
________

10/29/2025

Clinical development is still too slow, too manual, and too expensive, and “fully autonomous AI” is not a fix-all band-aid.

In their latest article, Andrew MacKinnon and Alison Holland explore how semi-autonomous agents are closing the gaps, replacing laborious admin and operational bottlenecks with faster, more reliable workflows that keep humans firmly in control.

It’s not about surrendering decision-making to machines when the stakes couldn't be higher. It’s about finally accessing the efficiency and consistency this industry has needed for decades, which means we can spend more time on patient care.

👉 Click here to read more: https://www.appliedclinicaltrialsonline.com/view/setting-limits-autonomy-autonomous-agents-clinical-research
________

As pharma wrestles with whether to trust fully autonomous AI, semi-autonomous agents are emerging as a safer middle ground that reduces manual work, eliminates white space in clinical development, and accelerates trial timelines without compromising patient safety.

10/29/2025

Life science innovation is entering a defining moment. Extraordinary AI breakthroughs are opening new frontiers in discovery and development, even as the industry continues to navigate complexity, cost, and scale.

At the center of it all are essential questions around responsibility, safety, and equity, and the decision on when human judgment should override algorithmic recommendations.

Tomorrow's panel during the Prix Galien Forum, featuring Medable CEO Dr. Michelle Longmire, brings together leaders who will explore what meaningful transformation will require and the early signals of real progress as it emerges.

Learn more here: https://www.galienfoundation.org/galien-forum-usa-2025-program
________
Panel line-up:
Ron Alfa, Co-Founder & Chief Executive Officer, NOETIK
Father Andrea Ciucci, COO, Pontifical Academy for Life, Vatican City; General Secretary, renAIssance Foundation
Michelle Longmire, Chief Executive Officer & Co-Founder, Medable
Tom Miller, Chief Executive Officer, Iambic Therapeutics
Marinka Zitnik, Associate Professor, Harvard in the Department of Biomedical Informatics
________

10/27/2025

Generic AI agents aren’t enough ❌. That’s why we created Agent Studio, built specifically to solve the complex challenges of life sciences🔬.

Intelligent. Compliant. Engineered for impact.

Send this account a DM to learn more! 📥